| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1Division of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-2650; 2Cardiovascular Research Institute and 3Departments of Medicine and Anesthesia, University of California, San Francisco, California 94143-2650
Submitted 20 December 2002 ; accepted in final form 11 May 2003
Decreased circulating protein C and increased circulating thrombomodulin are markers of the prothrombotic, antifibrinolytic state associated with poor outcomes in sepsis but have not been measured in patients with ALI (acute lung injury)/ARDS (acute respiratory distress syndrome). We measured circulating and intra-alveolar protein C and thrombomodulin in 45 patients with ALI/ARDS from septic and nonseptic causes and correlated the levels with clinical outcomes. Plasma protein C levels were lower in ALI/ARDS compared with normal. Lower levels of protein C were associated with worse clinical outcomes, including death, fewer ventilator-free days, and more nonpulmonary organ failures, even when only patients without sepsis were analyzed. Levels of thrombomodulin in pulmonary edema fluid from ALI/ARDS patients were >10-fold higher than normal plasma and 2-fold higher than ALI/ARDS plasma. Higher edema fluid thrombomodulin levels were associated with worse clinical outcomes. The higher levels in edema fluid compared with plasma suggest local release of soluble thrombomodulin in the lung, possibly from a lung epithelial source. To determine whether lung epithelial cells can release thrombomodulin, A549 cells and primary isolates of human alveolar type II cells were exposed to H2O2 or inflammatory cytokines. Both epithelial cell types released thrombomodulin into the media. In summary, the protein C system is markedly disrupted in patients with ALI/ARDS from both septic and nonseptic causes. The protein C system may be a potential therapeutic target in patients with ALI/ARDS.
acute respiratory distress syndrome; sepsis; endothelium; inflammation; coagulation
This article has been cited by other articles:
|
|
 |
|
  J. A. Bastarache, L. Wang, Z. Wang, K. H. Albertine, M. A. Matthay, and L. B. Ware Intra-alveolar tissue factor pathway inhibitor is not sufficient to block tissue factor procoagulant activity Am J Physiol Lung Cell Mol Physiol, May 1, 2008; 294(5): L874 - L881. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. D. Liu and M. A. Matthay Advances in Critical Care for the Nephrologist: Acute Lung Injury/ARDS Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(2): 578 - 586. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A Bastarache, L. Wang, T. Geiser, Z. Wang, K. H Albertine, M. A Matthay, and L. B Ware The alveolar epithelium can initiate the extrinsic coagulation cascade through expression of tissue factor Thorax, July 1, 2007; 62(7): 608 - 616. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. O. Mosnier, B. V. Zlokovic, and J. H. Griffin The cytoprotective protein C pathway Blood, April 15, 2007; 109(8): 3161 - 3172. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Wang, J. A. Bastarache, N. Wickersham, X. Fang, M. A. Matthay, and L. B. Ware Novel Role of the Human Alveolar Epithelium in Regulating Intra-Alveolar Coagulation Am. J. Respir. Cell Mol. Biol., April 1, 2007; 36(4): 497 - 503. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. S. Calfee and M. A. Matthay Nonventilatory Treatments for Acute Lung Injury and ARDS Chest, March 1, 2007; 131(3): 913 - 920. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Christie, N. Robinson, L. B. Ware, M. Plotnick, J. De Andrade, V. Lama, A. Milstone, J. Orens, A. Weinacker, E. Demissie, et al. Association of Protein C and Type 1 Plasminogen Activator Inhibitor with Primary Graft Dysfunction Am. J. Respir. Crit. Care Med., January 1, 2007; 175(1): 69 - 74. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. B. Ware, E. Camerer, K. Welty-Wolf, M. J. Schultz, and M. A. Matthay Bench to bedside: targeting coagulation and fibrinolysis in acute lung injury Am J Physiol Lung Cell Mol Physiol, September 1, 2006; 291(3): L307 - L311. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Cepkova and M. A. Matthay Pharmacotherapy of acute lung injury and the acute respiratory distress syndrome. J Intensive Care Med, May 1, 2006; 21(3): 119 - 143. [Abstract] [PDF]
|
|
|
|
|
|
G. R. Bernard Acute Respiratory Distress Syndrome: A Historical Perspective Am. J. Respir. Crit. Care Med., October 1, 2005; 172(7): 798 - 806. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. van der Poll, M. Levi, J. A. Nick, and E. Abraham Activated Protein C Inhibits Local Coagulation after Intrapulmonary Delivery of Endotoxin in Humans Am. J. Respir. Crit. Care Med., May 15, 2005; 171(10): 1125 - 1128. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. E. Parsons, M. A. Matthay, L. B. Ware, M. D. Eisner, and and the National Heart, Lung, Blood Institute Acut Elevated plasma levels of soluble TNF receptors are associated with morbidity and mortality in patients with acute lung injury Am J Physiol Lung Cell Mol Physiol, March 1, 2005; 288(3): L426 - L431. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. P. Bowler, B. Duda, E. D. Chan, J. J. Enghild, L. B. Ware, M. A. Matthay, and M. W. Duncan Proteomic analysis of pulmonary edema fluid and plasma in patients with acute lung injury Am J Physiol Lung Cell Mol Physiol, June 1, 2004; 286(6): L1095 - L1104. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. H. Hastings, H. G. Folkesson, and M. A. Matthay Mechanisms of alveolar protein clearance in the intact lung Am J Physiol Lung Cell Mol Physiol, April 1, 2004; 286(4): L679 - L689. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
